Diasorin LIAISON® Direct Renin - HSA Registration DE0507958
Access comprehensive regulatory information for Diasorin LIAISON® Direct Renin in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507958 and owned by DiaSorin Italia S.p.A.. The device was registered on March 30, 2023.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The LIAISON® Direct Renin assay uses chemiluminescence immunoassay (CLIA) technology for the in vitro quantitative determination of renin in human EDTA-plasma specimens. Renin measurement is of help in the diagnosis and treatment of a number of hypertension types in humans. The test has to be performed on the LIAISON® Analyzer family.